Venture capital survey reveals expectations gap between CEOs, VCs | Wall Street Beat

MassDevice.com Wall Street Beat

A survey of 158 CEOs and 216 venture capital firms revealed a large gap between the chief executives’ wish list for potential backers and what VCs think the CEOs want.

Startup CEOs in the IT and life science industries want VCs who are "entrepreneur friendly" and "collaborative" without being too hands-on in their approach, according to a survey sponsored by the National Venture Capital Assn.

And proximity trumps reach when it comes to location, with CEOs preferring VC shops with a presence in their area to VCs with bureaus around the globe, according to the survey.

Sign up to get our free newsletters delivered straight to your inbox

Gender matters too, with the CEO respondents, with 25% saying the gender balance among VC firms’ partners counts but only 10% of VCs citing gender balance as a factor.

"There is a gap between what CEOs are looking for in a VC firm and what VC firms believe CEOs want," according to the survey. "CEOs place great weight on what their peers and third parties say and think about your firm."

 Healthcare deals slide during H1 2013, but value rises 25%
There were 20.7% fewer merger & acquisition deals in the healthcare sector during the 1st half of the year, according to the Berkery Noyes investment bank, but the value of those deals rose 25% compared with H1 2012.

There were 157 deals worth a cumulative $8.0 billion during the 6 months ended June 1, compared with 198 deals worth $6.4 billion during the same period last year, according to the bank.
Read more

 Hansen, MiMedx release Q2 prelims

Hansen Medical (NSDQ:HNSN) shares were down more than 11% today after the robotic surgery company cut its sales forecast for the 2nd quarter, saying it expects revenues of $3.1 million to $3.4 million in the second quarter, down 4% to 12%. HNSN shares were trading at $1.25 apiece as of about 3:10 p.m. today, down 11.4%.

For its part, MiMedx (NSDQ:MDXG) said July 15 that it expects to beat the $13.5 million high end of its sales guidance. MDXG shares were trading at $5.91 as of about 3:10 p.m. today, down 1.0%.

 Biosense Technologies looks to crowd-fund its smartphone urinalysis system
Mountain View, California-based Biosense Technologies, maker of the uChek Universal smartphone-enabled urine analysis system, plans to crowdfund the device ahead of seeking 510(k) clearance from the FDA. 
Read more

 CAS Medical closes $6M round
CAS Medical Systems (NSDQ:CASM) said it will clear about $5.9 million from an offering of 5.2 million shares that closed yesterday. The shares went for $1.25 apiece, including a bloc of 3.2 million shares acquired by Deerfield Capital Management entities and Deerfield founder James Flynn.
Read more

 Analysts’ ups and downs

  • Bruker Corp. (NSDQ:BRKR): Cowen & Co. initiates coverage with “outperform” rating
  • Cyberonics (NSDQ:CYBX): Zacks downgrades from “outperform” to “neutral” rating, $55 price target
  • Edwards Lifesciences (NYSE:EW): Leerink Swann lowers price target to $80 from $85, maintains "outperform" rating.
  • Mallinckrodt plc (NYSE: MNK): Leerink Swann initiates coverage with “market perform” rating.
  • Philips (NYSE:PHG): JP Morgan Cazenove upgrades from “neutral” to “outperform” rating; JPMorgan Chase & Co. upgrades from “neutral” to “overweight” rating.
  • Stryker (NYSE:SYK): Citigroup reiterates "neutral" rating, raises price target from $72 to $78; Leerink Swann reiterates "outperform" rating, lifts price target to $79 from $74.

RSS From Medical Design & Outsourcing

  • VC funding in healthcare comes in at $1.2 billion in Q2 2015
    Mercom Capital Group, a global communications and research firm, released its report on funding and mergers and acquisitions (M&A) activity for the Healthcare Information Technology (IT) and Digital Health sector for the second quarter of 2015. Mercom’s comprehensive report covers deals of all sizes across the globe. Healthcare IT VC Funding Q2 2014 to Q2 […]
  • Schneider Electric’s new motor is ideal for small spaces
    Schneider Electric presents the smallest Lexium MDrive integrated motor, 1.7 in. (42mm) NEMA size 17, which delivers a large range of features to small spaces. Features that now include an IP65 rated version with industrial M12 connectors. M12 Lexium MDrive products provide a robust interface, with IP65 certification for protection against water and dust in […]
  • Emuge expands solid carbide thread mill program with new 3XD sizes
    Emuge is now offering an expanded line of Solid Carbide Thread Mills in their popular THREADS-ALL Program, to include new 3XD sizes designed for maximum reach. A total of 17 new sizes have been added, from miniature to standard size tools, providing maximum versatility in a wide range of thread milling applications. The 3XD THREADS-ALL […]
  • Start of helpful humanoid robots? CITEC uses compact LDS component as sensor array
    Editor’s Note: LaserMicronics, a service provider for laser-based manufacturing, has released the whitepaper “Robot hand with a sensitive touch: LDS tactile sensors for sensorimotor skills.” The paper describes a 2014 project from the CITEC department at Bielefeld University in Bielefeld, Germany, where researchers created a tactile sensor resembling a human fingertip. The sensor was then […]
  • Nature meets technology: Festo’s BionicANTs cooperate to solve a common task
    Editor’s Note: Festo, an industrial control and automation company, has released the whitepaper “BionicANTs: Cooperative behavior based on a natural model.” The paper describes the BionicANT, a creation of Festo engineers that duplicates the physical anatomy of its natural counterpart and reproduces the insect’s cooperative behavior. Festo engineers have used the delicate anatomy of an […]
  • Acorn Regulatory streamlines approval process drug-device manufacturers
    Acorn Regulatory, an ISO-certified medical device and pharmaceutical consulting firm, is streamlining procedures for U.S. manufacturers of drug-device combinations with customized programs that successfully overcome challenges in meeting European regulatory approvals. Focusing on small to mid-size companies, Acorn Regulatory has put in place a comprehensive step-by-step process that provides the correct regulatory pathway for medical […]
  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]

Leave a Reply